Safety and efficacy of regorafenib in patients with treatment-refractory metastatic colorectal cancer in Turkey: the single-arm, open-label REGARD study.
Faysal DaneKirhan OzgurdalŞuayib YalçınMustafa BenekliNuri Faruk Aykanİdris YücelMetin ÖzkanTurkkan EvrenselAlper SevinçHasan Şenol CoskunUlus Ali SanliIsmail Oguz KaraPerran Fulden YumukPublished in: BMJ open (2020)
NCT01853319, ClinicalTrials.gov.